Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Chronic lymphocytic leukemia in the elderly population

¹Division of Hematology-Oncology, Long Island Jewish Medical Center, New Hyde Park, NY 11040, USA.

Clinics in Geriatric Medicine

|May 1, 1997

Summary

Chronic lymphocytic leukemia (CLL) is a common elderly cancer. Fludarabine shows better response rates than chlorambucil for CLL treatment, offering an effective salvage therapy option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Somatic CLL mutations occur at multiple distinct hematopoietic maturation stages: documentation and cautionary note regarding cell fraction purity.

Leukemia·2017

Same author

Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia.

Leukemia·2017

Same author

BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia.

Leukemia·2015

Same author

Cytoplasmic myosin-exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability.

Leukemia·2015

Same author

Study of medically important Vibrios in the sewage of Katmandu Valley, Nepal.

Nepal Medical College journal : NMCJ·2013

Same author

Study of parasitic infection among children of Sukumbasi Basti in Kathmandu valley.

Nepal Medical College journal : NMCJ·2011

Area of Science:

Hematology
Oncology
Geriatric Medicine

Background:

Chronic lymphocytic leukemia (CLL) predominantly affects the elderly population.
Current chemotherapy like chlorambucil manages CLL symptoms but does not extend survival.
Prednisone use in elderly CLL patients requires caution due to potential side effects.

Purpose of the Study:

To compare the efficacy of fludarabine with chlorambucil in treating CLL.
To evaluate fludarabine as a salvage therapy for CLL patients.

Main Methods:

Comparative analysis of treatment outcomes for CLL patients.
Assessment of response rates and salvage therapy effectiveness.

Main Results:

Fludarabine demonstrates superior response rates compared to chlorambucil in CLL treatment.
Fludarabine is effective as a salvage therapy for patients previously treated with chlorambucil.

Conclusions:

Fludarabine offers improved efficacy over chlorambucil for CLL management.
Fludarabine represents a valuable therapeutic option for relapsed or refractory CLL.

Related Experiment Videos